{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T00:43:17Z","timestamp":1794012197815,"version":"4.8.0"},"reference-count":113,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Stadapharm GmbH"},{"DOI":"10.13039\/501100012681","name":"Universit\u00e4tsklinikum K\u00f6ln","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012681","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cognitive impairment is common in Parkinson\u2019s disease (PD). Up to 80% of people with PD develop dementia over the disease course, heavily impacting their quality of life. While pharmacological treatment options are scarce, previous research highlights the potential benefits of non-pharmacological interventions, such as cognitive training (CT), on cognition and non-cognitive outcomes. This study\u2019s purpose is to examine the feasibility as well as short- and long-term effects of a 5-week digital CT in people with advanced PD, compared to people with advanced PD receiving care as usual, and to explore possible predictors of CT responsiveness.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This ongoing monocentric, two-armed randomized controlled trial (RCT) seeks to include 140 participants with advanced PD according to the established 5-2-1 criteria. Participants are randomized into either the experimental group, receiving a structured 5-week digital CT and additional psychoeducational videos on cognitive health, or a passive control group receiving care as usual. CT will be carried out remotely from home and supervised by the study team. Feasibility will be assessed using a training diary (e.g., motivation, satisfaction) and technical data (e.g., training duration). Neuropsychological assessments will be carried out pre- and post-CT and after a 3-month follow-up period. The primary outcome will be global cognition measured with the Montr\u00e9al Cognitive Assessment (MoCA). Secondary outcomes include further cognitive, motor, and (neuro)psychological variables (e.g., quality of life, motor symptoms, mood, activities of daily living).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Studies on CT in people with PD have demonstrated positive effects on cognition, promoting the application of CT as a non-pharmacological treatment approach. However, studies targeting people in more advanced PD stages are rare or non-existent, despite it being a clinically relevant target group. Further, few studies have looked at long-term CT effects in PD, and very little data exists regarding CT predictors. Therefore, this large-cohort study of a multi-domain digital CT in people with advanced PD aims to provide insights into the effects, feasibility, and acceptability of CT within a representative sample of people with PD, allowing for statistically high-powered analyses and the identification of potential CT predictors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>German Clinical Trials Register (DRKS) DRKS00028876. Registered on 21 November 2022<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13063-025-09330-7","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:33:24Z","timestamp":1766536404000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Computerized cognitive training vs. care as usual to strengthen cognitive, motor, and (neuro)psychological outcomes in people with advanced Parkinson\u2019s disease (TrainParC-Advanced): study protocol of a randomized controlled trial"],"prefix":"10.1186","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3972-3567","authenticated-orcid":false,"given":"Paulina M.","family":"Olgem\u00f6ller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8603-2545","authenticated-orcid":false,"given":"Elke","family":"Kalbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2091-4638","authenticated-orcid":false,"given":"Christina","family":"van der Linden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1149-8054","authenticated-orcid":false,"given":"Michael T.","family":"Barbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5174-928X","authenticated-orcid":false,"given":"Martin","family":"Hellmich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2168-140X","authenticated-orcid":false,"given":"Ann-Kristin","family":"Folkerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,24]]},"reference":[{"key":"9330_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031851","volume":"23","author":"RNL Lamptey","year":"2022","unstructured":"Lamptey RNL, Chaulagain B, Trivedi R, Gothwal A, Layek B, Singh J. A review of the common neurodegenerative disorders: current therapeutic approaches and the potential role of nanotherapeutics. Int J Mol Sci. 2022;23:1851. https:\/\/doi.org\/10.3390\/ijms23031851.","journal-title":"Int J Mol Sci"},{"key":"9330_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3233\/JPD-181474","volume":"8","author":"ER Dorsey","year":"2018","unstructured":"Dorsey ER, Sherer T, Okun MS, Bloem BR. The emerging evidence of the Parkinson pandemic. J Park Dis. 2018;8:3\u20138. https:\/\/doi.org\/10.3233\/JPD-181474.","journal-title":"J Park Dis"},{"key":"9330_CR3","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/S1474-4422(24)00038-3","volume":"23","author":"JD Steinmetz","year":"2024","unstructured":"Steinmetz JD, Seeher KM, Schiess N, Nichols E, Cao B, Servili C, et al. Global, regional, and national burden of disorders affecting the nervous system, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol. 2024;23:344\u201381. https:\/\/doi.org\/10.1016\/S1474-4422(24)00038-3.","journal-title":"Lancet Neurol"},{"key":"9330_CR4","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, et al. MDS clinical diagnostic criteria for Parkinson\u2019s disease: MDS-PD clinical diagnostic criteria. Mov Disord. 2015;30:1591\u2013601. https:\/\/doi.org\/10.1002\/mds.26424.","journal-title":"Mov Disord"},{"key":"9330_CR5","unstructured":"H\u00f6glinger G, Trenkwalder C, et. al. Parkinson-Krankheit, S2k-Leitlinie. Leitlinien F\u00fcr Diagn Ther Neurol. 2023."},{"key":"9330_CR6","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jama.2019.22360","volume":"323","author":"MJ Armstrong","year":"2020","unstructured":"Armstrong MJ, Okun MS. Diagnosis and treatment of Parkinson disease: a review. JAMA. 2020;323:548. https:\/\/doi.org\/10.1001\/jama.2019.22360.","journal-title":"JAMA"},{"key":"9330_CR7","doi-asserted-by":"publisher","unstructured":"Rodriguez\u2010Blazquez C, Schrag A, Rizos A, Chaudhuri KR, Martinez\u2010Martin P, Weintraub D. Prevalence of non\u2010motor symptoms and non\u2010motor fluctuations in Parkinson\u2019s disease using the MDS\u2010NMS. Mov Disord Clin Pract. 2021;8:231\u20139. https:\/\/doi.org\/10.1002\/mdc3.13122.","DOI":"10.1002\/mdc3.13122"},{"key":"9330_CR8","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41572-021-00280-3","volume":"7","author":"D Aarsland","year":"2021","unstructured":"Aarsland D, Batzu L, Halliday GM, Geurtsen GJ, Ballard C, Ray Chaudhuri K, et al. Parkinson disease-associated cognitive impairment. Nat Rev Dis Primers. 2021;7:47. https:\/\/doi.org\/10.1038\/s41572-021-00280-3.","journal-title":"Nat Rev Dis Primers"},{"key":"9330_CR9","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.nrleng.2014.10.016","volume":"31","author":"K Berganzo","year":"2016","unstructured":"Berganzo K, Tijero B, Gonz\u00e1lez-Eizaguirre A, Somme J, Lezcano E, Gabilondo I, et al. Motor and non-motor symptoms of Parkinson\u2019s disease and their impact on quality of life and on different clinical subgroups. Neurolog\u00eda (English Edition). 2016;31:585\u201391. https:\/\/doi.org\/10.1016\/j.nrleng.2014.10.016.","journal-title":"Neurolog\u00eda (English Edition)"},{"key":"9330_CR10","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.parkreldis.2016.01.002","volume":"24","author":"O Monchi","year":"2016","unstructured":"Monchi O, Hanganu A, Bellec P. Markers of cognitive decline in PD: the case for heterogeneity. Parkinsonism Relat Disord. 2016;24:8\u201314. https:\/\/doi.org\/10.1016\/j.parkreldis.2016.01.002.","journal-title":"Parkinsonism Relat Disord"},{"key":"9330_CR11","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1002\/mdc3.13451","volume":"9","author":"JA Boel","year":"2022","unstructured":"Boel JA, De Bie RMA, Schmand BA, Dalrymple\u2010Alford JC, Marras C, Adler CH, et al. Level I PD\u2010MCI using global cognitive tests and the risk for Parkinson\u2019s disease dementia. Mov Disord Clin Pract. 2022;9:479\u201383. https:\/\/doi.org\/10.1002\/mdc3.13451.","journal-title":"Mov Disord Clin Pract"},{"key":"9330_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-018-0055-3","volume":"4","author":"JG Goldman","year":"2018","unstructured":"Goldman JG, Vernaleo BA, Camicioli R, Dahodwala N, Dobkin RD, Ellis T, et al. Cognitive impairment in Parkinson\u2019s disease: a report from a multidisciplinary symposium on unmet needs and future directions to maintain cognitive health. NPJ Parkinsons Dis. 2018;4:19. https:\/\/doi.org\/10.1038\/s41531-018-0055-3.","journal-title":"NPJ Parkinsons Dis"},{"key":"9330_CR13","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/mds.27902","volume":"35","author":"C Baiano","year":"2020","unstructured":"Baiano C, Barone P, Trojano L, Santangelo G. Prevalence and clinical aspects of mild cognitive impairment in Parkinson\u2019s disease: a meta\u2010analysis. Mov Disord. 2020;35:45\u201354. https:\/\/doi.org\/10.1002\/mds.27902.","journal-title":"Mov Disord"},{"key":"9330_CR14","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1007\/s00415-018-8800-4","volume":"265","author":"R Monastero","year":"2018","unstructured":"Monastero R, Cicero CE, Baschi R, Dav\u00ec M, Luca A, Restivo V, et al. Mild cognitive impairment in Parkinson\u2019s disease: the Parkinson\u2019s disease cognitive study (PACOS). J Neurol. 2018;265:1050\u20138. https:\/\/doi.org\/10.1007\/s00415-018-8800-4.","journal-title":"J Neurol"},{"key":"9330_CR15","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1212\/01.wnl.0000180516.69442.95","volume":"65","author":"D Muslimovi\u0107","year":"2005","unstructured":"Muslimovi\u0107 D, Post B, Speelman JD, Schmand B. Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology. 2005;65:1239\u201345. https:\/\/doi.org\/10.1212\/01.wnl.0000180516.69442.95.","journal-title":"Neurology"},{"key":"9330_CR16","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jns.2017.01.012","volume":"374","author":"HA Hanagasi","year":"2017","unstructured":"Hanagasi HA, Tufekcioglu Z, Emre M. Dementia in Parkinson\u2019s disease. J Neurol Sci. 2017;374:26\u201331. https:\/\/doi.org\/10.1016\/j.jns.2017.01.012.","journal-title":"J Neurol Sci"},{"key":"9330_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2021.120077","volume":"432","author":"C Severiano E Sousa","year":"2022","unstructured":"Severiano E Sousa C, Alarc\u00e3o J, Pav\u00e3o Martins I, Ferreira JJ. Frequency of dementia in Parkinson\u2019s disease: a systematic review and meta-analysis. J Neurol Sci. 2022;432:120077. https:\/\/doi.org\/10.1016\/j.jns.2021.120077.","journal-title":"J Neurol Sci"},{"key":"9330_CR18","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/mds.21956","volume":"23","author":"MA Hely","year":"2008","unstructured":"Hely MA, Reid WGJ, Adena MA, Halliday GM, Morris JGL. The Sydney multicenter study of Parkinson\u2019s disease: the inevitability of dementia at 20 years. Mov Disord. 2008;23:837\u201344. https:\/\/doi.org\/10.1002\/mds.21956.","journal-title":"Mov Disord"},{"key":"9330_CR19","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1002\/gps.4623","volume":"32","author":"R Lawson","year":"2017","unstructured":"Lawson R, Yarnall A, Johnston F, Duncan G, Khoo T, Collerton D, et al. Cognitive impairment in Parkinson\u2019s disease: impact on quality of life of carers. Int J Geriatr Psychiatry. 2017;32:1362\u201370. https:\/\/doi.org\/10.1002\/gps.4623.","journal-title":"Int J Geriatr Psychiatry"},{"key":"9330_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/1362053","volume":"2018","author":"RA Lawson","year":"2018","unstructured":"Lawson RA, Collerton D, Taylor J-P, Burn DJ, Brittain KR. Coping with cognitive impairment in people with Parkinson\u2019s disease and their carers: a qualitative study. Parkinsons Dis. 2018;2018:1\u201310. https:\/\/doi.org\/10.1155\/2018\/1362053.","journal-title":"Parkinsons Dis"},{"key":"9330_CR21","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1159\/000478849","volume":"7","author":"D Wiesli","year":"2017","unstructured":"Wiesli D, Meyer A, Fuhr P, Gschwandtner U. Influence of mild cognitive impairment, depression, and anxiety on the quality of life of patients with Parkinson disease. Dement Geriatr Cogn Disord Extra. 2017;7:297\u2013308. https:\/\/doi.org\/10.1159\/000478849.","journal-title":"Dement Geriatr Cogn Disord Extra"},{"key":"9330_CR22","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.parkreldis.2014.02.030","volume":"20","author":"LML De Lau","year":"2014","unstructured":"De Lau LML, Verbaan D, Marinus J, Van Hilten JJ. Survival in Parkinson\u2019s disease. Relation with motor and non-motor features. Parkinsonism Relat Disord. 2014;20:613\u20136. https:\/\/doi.org\/10.1016\/j.parkreldis.2014.02.030.","journal-title":"Parkinsonism Relat Disord"},{"key":"9330_CR23","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1111\/ene.14584","volume":"28","author":"R Dodel","year":"2021","unstructured":"Dodel R, Tinelli M, Deuschl G, Petersen G, Oertel W, Ahmerkamp\u2010B\u00f6hme J. The economic benefit of timely, adequate, and adherence to Parkinson\u2019s disease treatment: the value of treatment project 2. Eur J Neurol. 2021;28:707\u201316. https:\/\/doi.org\/10.1111\/ene.14584.","journal-title":"Eur J Neurol"},{"key":"9330_CR24","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1002\/mds.23661","volume":"26","author":"C Vossius","year":"2011","unstructured":"Vossius C, Larsen JP, Janvin C, Aarsland D. The economic impact of cognitive impairment in Parkinson\u2019s disease. Mov Disord. 2011;26:1541\u20134. https:\/\/doi.org\/10.1002\/mds.23661.","journal-title":"Mov Disord"},{"key":"9330_CR25","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3389\/fnagi.2019.00303","volume":"11","author":"DM Cammisuli","year":"2019","unstructured":"Cammisuli DM, Cammisuli SM, Fusi J, Franzoni F, Pruneti C. Parkinson\u2019s disease-mild cognitive impairment (PD-MCI): a useful summary of update knowledge. Front Aging Neurosci. 2019;11:303. https:\/\/doi.org\/10.3389\/fnagi.2019.00303.","journal-title":"Front Aging Neurosci"},{"key":"9330_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/bs11040054","volume":"11","author":"C Sun","year":"2021","unstructured":"Sun C, Armstrong MJ. Treatment of Parkinson\u2019s disease with cognitive impairment: current approaches and future directions. Behav Sci. 2021;11:54. https:\/\/doi.org\/10.3390\/bs11040054.","journal-title":"Behav Sci"},{"key":"9330_CR27","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1007\/s00702-019-02026-8","volume":"126","author":"I Csoti","year":"2019","unstructured":"Csoti I, Herbst H, Urban P, Woitalla D, W\u00fcllner U. Polypharmacy in Parkinson\u2019s disease: risks and benefits with little evidence. J Neural Transm. 2019;126:871\u20138. https:\/\/doi.org\/10.1007\/s00702-019-02026-8.","journal-title":"J Neural Transm"},{"key":"9330_CR28","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1159\/000502351","volume":"9","author":"N Ishii","year":"2019","unstructured":"Ishii N, Mochizuki H, Sakai K, Ogawa G, Shiomi K, Nakazato M. Polypharmacy associated with cognitive decline in newly diagnosed Parkinson\u2019s disease: a cross-sectional study. Dement Geriatr Cogn Disord Extra. 2019;9:338\u201343. https:\/\/doi.org\/10.1159\/000502351.","journal-title":"Dement Geriatr Cogn Disord Extra"},{"key":"9330_CR29","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1212\/WNL.0000000000002145","volume":"85","author":"IHK Leung","year":"2015","unstructured":"Leung IHK, Walton CC, Hallock H, Lewis SJG, Valenzuela M, Lampit A. Cognitive training in Parkinson disease: a systematic review and meta-analysis. Neurology. 2015;85:1843\u201351. https:\/\/doi.org\/10.1212\/WNL.0000000000002145.","journal-title":"Neurology"},{"key":"9330_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011961.pub2","author":"V Orgeta","year":"2020","unstructured":"Orgeta V, McDonald KR, Poliakoff E, Hindle JV, Clare L, Leroi I. Cognitive training interventions for dementia and mild cognitive impairment in Parkinson\u2019s disease. Cochrane Database Syst Rev. 2020. https:\/\/doi.org\/10.1002\/14651858.CD011961.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"9330_CR31","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1177\/1545968317712468","volume":"31","author":"BJ Lawrence","year":"2017","unstructured":"Lawrence BJ, Gasson N, Bucks RS, Troeung L, Loftus AM. Cognitive training and noninvasive brain stimulation for cognition in Parkinson\u2019s disease: a meta-analysis. Neurorehabil Neural Repair. 2017;31:597\u2013608. https:\/\/doi.org\/10.1177\/1545968317712468.","journal-title":"Neurorehabil Neural Repair"},{"key":"9330_CR32","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1080\/13825585.2018.1513450","volume":"26","author":"M Couture","year":"2019","unstructured":"Couture M, Gigu\u00e8re-Rancourt A, Simard M. The impact of cognitive interventions on cognitive symptoms in idiopathic Parkinson\u2019s disease: a systematic review. Aging Neuropsychol Cogn. 2019;26:637\u201359. https:\/\/doi.org\/10.1080\/13825585.2018.1513450.","journal-title":"Aging Neuropsychol Cogn"},{"key":"9330_CR33","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1093\/arclin\/acz080","volume":"35","author":"A Nousia","year":"2020","unstructured":"Nousia A, Martzoukou M, Tsouris Z, Siokas V, Aloizou A-M, Liampas I, et al. The beneficial effects of computer-based cognitive training in Parkinson\u2019s disease: a systematic review. Arch Clin Neuropsychol. 2020;35:434\u201347. https:\/\/doi.org\/10.1093\/arclin\/acz080.","journal-title":"Arch Clin Neuropsychol"},{"key":"9330_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2022.101671","volume":"80","author":"HM Gavelin","year":"2022","unstructured":"Gavelin HM, Domell\u00f6f ME, Leung I, Neely AS, Launder NH, Nategh L, et al. Computerized cognitive training in Parkinson\u2019s disease: a systematic review and meta-analysis. Ageing Res Rev. 2022;80:101671. https:\/\/doi.org\/10.1016\/j.arr.2022.101671.","journal-title":"Ageing Res Rev"},{"key":"9330_CR35","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1176\/appi.ajp.2016.16030360","volume":"174","author":"NTM Hill","year":"2017","unstructured":"Hill NTM, Mowszowski L, Naismith SL, Chadwick VL, Valenzuela M, Lampit A. Computerized cognitive training in older adults with mild cognitive impairment or dementia: a systematic review and meta-analysis. Am J Psychiatry. 2017;174:329\u201340. https:\/\/doi.org\/10.1176\/appi.ajp.2016.16030360.","journal-title":"Am J Psychiatry"},{"key":"9330_CR36","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1001\/archneur.60.3.387","volume":"60","author":"D Aarsland","year":"2003","unstructured":"Aarsland D, Andersen K, Larsen JP, Lolk A. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol. 2003;60:387. https:\/\/doi.org\/10.1001\/archneur.60.3.387.","journal-title":"Arch Neurol"},{"key":"9330_CR37","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1177\/1545968316680489","volume":"31","author":"CC Walton","year":"2017","unstructured":"Walton CC, Naismith SL, Lampit A, Mowszowski L, Lewis SJG. Cognitive training in Parkinson\u2019s disease: a theoretical perspective. Neurorehabil Neural Repair. 2017;31:207\u201316. https:\/\/doi.org\/10.1177\/1545968316680489.","journal-title":"Neurorehabil Neural Repair"},{"key":"9330_CR38","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1177\/1545968320981956","volume":"35","author":"A Ophey","year":"2021","unstructured":"Ophey A, Rehberg S, Giehl K, Eggers C, Reker P, Van Eimeren T, et al. Predicting working memory training responsiveness in Parkinson\u2019s disease: both \u201csystem hardware\u201d and room for improvement are needed. Neurorehabil Neural Repair. 2021;35:117\u201330. https:\/\/doi.org\/10.1177\/1545968320981956.","journal-title":"Neurorehabil Neural Repair"},{"key":"9330_CR39","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ijmedinf.2018.04.005","volume":"115","author":"A Alloni","year":"2018","unstructured":"Alloni A, Quaglini S, Panzarasa S, Sinforiani E, Bernini S. Evaluation of an ontology-based system for computerized cognitive rehabilitation. Int J Med Inform. 2018;115:64\u201372. https:\/\/doi.org\/10.1016\/j.ijmedinf.2018.04.005.","journal-title":"Int J Med Inform"},{"key":"9330_CR40","doi-asserted-by":"publisher","first-page":"555","DOI":"10.3233\/NRE-192714","volume":"44","author":"S Bernini","year":"2019","unstructured":"Bernini S, Alloni A, Panzarasa S, Picascia M, Quaglini S, Tassorelli C, et al. A computer-based cognitive training in mild cognitive impairment in Parkinson\u2019s disease. NeuroRehabilitation. 2019;44:555\u201367. https:\/\/doi.org\/10.3233\/NRE-192714.","journal-title":"NeuroRehabilitation"},{"key":"9330_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/8104673","volume":"2018","author":"A-K Folkerts","year":"2018","unstructured":"Folkerts A-K, Dorn ME, Roheger M, Maassen M, Koerts J, Tucha O, et al. Cognitive stimulation for individuals with Parkinson\u2019s disease dementia living in long-term care: preliminary data from a randomized crossover pilot study. Parkinsons Dis. 2018;2018:1\u20139. https:\/\/doi.org\/10.1155\/2018\/8104673.","journal-title":"Parkinsons Dis"},{"key":"9330_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/5258493","volume":"2019","author":"SJ Smith","year":"2019","unstructured":"Smith SJ, McMillan I, Leroi I, Champ CL, Barr S, McDonald KR, et al. Feasibility and acceptability of computerised cognitive training of everyday cognition in Parkinson\u2019s disease. Parkinsons Dis. 2019;2019:1\u201311. https:\/\/doi.org\/10.1155\/2019\/5258493.","journal-title":"Parkinsons Dis"},{"key":"9330_CR43","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1159\/000509685","volume":"83","author":"SCF Van De Weijer","year":"2020","unstructured":"Van De Weijer SCF, Duits AA, Bloem BR, De Vries NM, Kessels RPC, K\u00f6hler S, et al. Feasibility of a cognitive training game in Parkinson\u2019s disease: the randomized Parkin\u2019Play study. Eur Neurol. 2020;83:426\u201332. https:\/\/doi.org\/10.1159\/000509685.","journal-title":"Eur Neurol"},{"key":"9330_CR44","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/4068706","author":"E Kalbe","year":"2020","unstructured":"Kalbe E, Folkerts A-K, Ophey A, Eggers C, Elben S, Dimenshteyn K, et al. Enhancement of executive functions but not memory by multidomain group cognitive training in patients with Parkinson\u2019s disease and mild cognitive impairment: a multicenter randomized controlled trial. Parkinsons Dis. 2020. https:\/\/doi.org\/10.1155\/2020\/4068706.","journal-title":"Parkinsons Dis"},{"key":"9330_CR45","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1177\/08919887211018277","volume":"34","author":"H Hwang","year":"2021","unstructured":"Hwang H, Norris SA. Managing advanced Parkinson disease. J Geriatr Psychiatry Neurol. 2021;34:289\u2013300. https:\/\/doi.org\/10.1177\/08919887211018277.","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"9330_CR46","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1007\/s00702-017-1707-x","volume":"124","author":"R Kr\u00fcger","year":"2017","unstructured":"Kr\u00fcger R, Klucken J, Weiss D, T\u00f6nges L, Kolber P, Unterecker S, et al. Classification of advanced stages of Parkinson\u2019s disease: translation into stratified treatments. J Neural Transm. 2017;124:1015\u201327. https:\/\/doi.org\/10.1007\/s00702-017-1707-x.","journal-title":"J Neural Transm"},{"key":"9330_CR47","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1007\/s00702-017-1799-3","volume":"124","author":"N Titova","year":"2017","unstructured":"Titova N, Martinez-Martin P, Katunina E, Chaudhuri KR. Advanced Parkinson\u2019s or \u201ccomplex phase\u201d Parkinson\u2019s disease? Re-evaluation is needed. J Neural Transm. 2017;124:1529\u201337. https:\/\/doi.org\/10.1007\/s00702-017-1799-3.","journal-title":"J Neural Transm"},{"key":"9330_CR48","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nrneurol.2017.27","volume":"13","author":"D Aarsland","year":"2017","unstructured":"Aarsland D, Creese B, Politis M, Chaudhuri KR, Ffytche DH, Weintraub D, et al. Cognitive decline in Parkinson disease. Nat Rev Neurol. 2017;13:217\u201331. https:\/\/doi.org\/10.1038\/nrneurol.2017.27.","journal-title":"Nat Rev Neurol"},{"key":"9330_CR49","doi-asserted-by":"publisher","first-page":"4655","DOI":"10.1007\/s00415-021-10568-9","volume":"268","author":"N Schmidt","year":"2021","unstructured":"Schmidt N, T\u00f6dt I, Berg D, Schlenstedt C, Folkerts A-K, Ophey A, et al. Memory enhancement by multidomain group cognitive training in patients with Parkinson\u2019s disease and mild cognitive impairment: long-term effects of a multicenter randomized controlled trial. J Neurol. 2021;268:4655\u201366. https:\/\/doi.org\/10.1007\/s00415-021-10568-9.","journal-title":"J Neurol"},{"key":"9330_CR50","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.3233\/JPD-223448","volume":"12","author":"A Ophey","year":"2022","unstructured":"Ophey A, Wenzel J, Paul R, Giehl K, Rehberg S, Eggers C, et al. Cognitive performance and learning parameters predict response to working memory training in Parkinson\u2019s disease. J Parkinsons Dis. 2022;12:2235\u201347. https:\/\/doi.org\/10.3233\/JPD-223448.","journal-title":"J Parkinsons Dis"},{"key":"9330_CR51","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s41512-020-0071-8","volume":"4","author":"M Roheger","year":"2020","unstructured":"Roheger M, Folkerts A-K, Krohm F, Skoetz N, Kalbe E. Prognostic factors for change in memory test performance after memory training in healthy older adults: a systematic review and outline of statistical challenges. Diagn Progn Res. 2020;4:7. https:\/\/doi.org\/10.1186\/s41512-020-0071-8.","journal-title":"Diagn Progn Res"},{"key":"9330_CR52","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1037\/pag0000442","volume":"35","author":"C Basak","year":"2020","unstructured":"Basak C, Qin S, O\u2019Connell MA. Differential effects of cognitive training modules in healthy aging and mild cognitive impairment: a comprehensive meta-analysis of randomized controlled trials. Psychol Aging. 2020;35:220\u201349. https:\/\/doi.org\/10.1037\/pag0000442.","journal-title":"Psychol Aging"},{"key":"9330_CR53","doi-asserted-by":"publisher","first-page":"636355","DOI":"10.3389\/fnhum.2021.636355","volume":"15","author":"M Roheger","year":"2021","unstructured":"Roheger M, Liebermann-Jordanidis H, Krohm F, Adams A, Kalbe E. Prognostic factors and models for changes in cognitive performance after multi-domain cognitive training in healthy older adults: a systematic review. Front Hum Neurosci. 2021;15:636355. https:\/\/doi.org\/10.3389\/fnhum.2021.636355.","journal-title":"Front Hum Neurosci"},{"key":"9330_CR54","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/MLR.0b013e3182408812","volume":"50","author":"GM Curran","year":"2012","unstructured":"Curran GM, Bauer M, Mittman B, Pyne JM, Stetler C. Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact. Med Care. 2012;50:217\u201326. https:\/\/doi.org\/10.1097\/MLR.0b013e3182408812.","journal-title":"Med Care"},{"key":"9330_CR55","unstructured":"Baller G, Folkerts A-K, Bintener C, Kessler J, Kalbe E. HeadApp\/NEUROvitalis Digital. 2020. https:\/\/start-headapp.helferservices.net\/."},{"key":"9330_CR56","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","volume":"53","author":"ZS Nasreddine","year":"2005","unstructured":"Nasreddine ZS, Phillips NA, B\u00e9dirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695\u20139. https:\/\/doi.org\/10.1111\/j.1532-5415.2005.53221.x.","journal-title":"J Am Geriatr Soc"},{"key":"9330_CR57","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1136\/jnnp.51.6.745","volume":"51","author":"WR Gibb","year":"1988","unstructured":"Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. 1988;51:745\u201352. https:\/\/doi.org\/10.1136\/jnnp.51.6.745.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9330_CR58","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1080\/03007995.2018.1502165","volume":"34","author":"A Antonini","year":"2018","unstructured":"Antonini A, Stoessl AJ, Kleinman LS, Skalicky AM, Marshall TS, Sail KR, et al. Developing consensus among movement disorder specialists on clinical indicators for identification and management of advanced Parkinson\u2019s disease: a multi-country Delphi-panel approach. Curr Med Res Opin. 2018;34:2063\u201373. https:\/\/doi.org\/10.1080\/03007995.2018.1502165.","journal-title":"Curr Med Res Opin"},{"key":"9330_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/7537924","volume":"2020","author":"D Santos-Garc\u00eda","year":"2020","unstructured":"Santos-Garc\u00eda D, De Deus Fonticoba T, Su\u00e1rez Castro E, Aneiros D\u00edaz A, McAfee D. 5-2-1 criteria: a simple screening tool for identifying advanced PD patients who need an optimization of Parkinson\u2019s treatment. Parkinsons Dis. 2020;2020:1\u20136. https:\/\/doi.org\/10.1155\/2020\/7537924.","journal-title":"Parkinsons Dis"},{"key":"9330_CR60","doi-asserted-by":"publisher","unstructured":"Dalrymple-Alford JC. Well-suited screen for cognitive impairment in Parkinson disease. Neurology. 2010:1717\u201325. https:\/\/doi.org\/10.1212\/WNL.0b013e3181fc29c9.","DOI":"10.1212\/WNL.0b013e3181fc29c9"},{"key":"9330_CR61","doi-asserted-by":"publisher","unstructured":"Beck AT, Steer RA, Brown G. Beck Depression Inventory\u2013II (BDI-II). 1996. https:\/\/doi.org\/10.1037\/t00742-000.","DOI":"10.1037\/t00742-000"},{"key":"9330_CR62","unstructured":"World Medical Association. WMA Declaration of Helsiniki - Ethical Principles for Medical Research Involving Human Participants. 2024. https:\/\/www.wma.net\/policies-post\/wma-declaration-of-helsinki\/. Accessed 31 Oct 2025."},{"key":"9330_CR63","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp074045","author":"PS Appelbaum","year":"2007","unstructured":"Appelbaum PS. Assessment of patients\u2019 competence to consent to treatment. N Engl J Med. 2007. https:\/\/doi.org\/10.1056\/NEJMcp074045.","journal-title":"N Engl J Med"},{"key":"9330_CR64","volume-title":"NEUROvitalis","author":"G Baller","year":"2010","unstructured":"Baller G, Kalbe E, Kaseberg S, Kessler J. NEUROvitalis. K\u00f6ln: ProLog Therapie; 2010."},{"key":"9330_CR65","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1016\/j.parkreldis.2014.08.023","volume":"20","author":"A Petrelli","year":"2014","unstructured":"Petrelli A, Kaesberg S, Barbe MT, Timmermann L, Fink GR, Kessler J, et al. Effects of cognitive training in Parkinson\u2019s disease: a randomized controlled trial. Parkinsonism Relat Disord. 2014;20:1196\u2013202. https:\/\/doi.org\/10.1016\/j.parkreldis.2014.08.023.","journal-title":"Parkinsonism Relat Disord"},{"key":"9330_CR66","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/ene.12621","volume":"22","author":"A Petrelli","year":"2015","unstructured":"Petrelli A, Kaesberg S, Barbe MT, Timmermann L, Rosen JB, Fink GR, et al. Cognitive training in Parkinson\u2019s disease reduces cognitive decline in the long term. Eur J Neurol. 2015;22:640\u20137. https:\/\/doi.org\/10.1111\/ene.12621.","journal-title":"Eur J Neurol"},{"key":"9330_CR67","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1097\/WNN.0000000000000195","volume":"32","author":"M Roheger","year":"2019","unstructured":"Roheger M, Kessler J, Kalbe E. Structured cognitive training yields best results in healthy older adults, and their ApoE4 state and baseline cognitive level predict training benefits. Cogn Behav Neurol. 2019;32:76\u201386. https:\/\/doi.org\/10.1097\/WNN.0000000000000195.","journal-title":"Cogn Behav Neurol"},{"key":"9330_CR68","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.parkreldis.2020.02.002","volume":"72","author":"A Ophey","year":"2020","unstructured":"Ophey A, Giehl K, Rehberg S, Eggers C, Reker P, Van Eimeren T, et al. Effects of working memory training in patients with Parkinson\u2019s disease without cognitive impairment: a randomized controlled trial. Parkinsonism Relat Disord. 2020;72:13\u201322. https:\/\/doi.org\/10.1016\/j.parkreldis.2020.02.002.","journal-title":"Parkinsonism Relat Disord"},{"key":"9330_CR69","unstructured":"Bartusch S, Zipper S. Montr\u00e9al Cognitive Assessment (MoCA): German version. 2004."},{"key":"9330_CR70","unstructured":"International Parkinson and Movemend Disorder Society (MDS). MDS-Reccomended Rating Scales. https:\/\/www.movementdisorders.org\/MDS\/Education\/Rating-Scales\/MDS-Recommended-Rating-Scales.htm. Accessed 31 Oct 2025."},{"key":"9330_CR71","doi-asserted-by":"publisher","first-page":"7330","DOI":"10.1007\/s00415-024-12503-0","volume":"271","author":"E Kalbe","year":"2024","unstructured":"Kalbe E, Folkerts A-K, Witt K, Buhmann C, Liepelt-Scarfone I, German Parkinson\u2019s Guidelines Group. German society of neurology guidelines for the diagnosis and treatment of cognitive impairment and affective disorders in people with Parkinson\u2019s disease: new spotlights on diagnostic procedures and non-pharmacological interventions. J Neurol. 2024;271:7330\u201357. https:\/\/doi.org\/10.1007\/s00415-024-12503-0.","journal-title":"J Neurol"},{"key":"9330_CR72","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1017\/S003329170600938X","volume":"37","author":"MJ Valenzuela","year":"2007","unstructured":"Valenzuela MJ, Sachdev P. Assessment of complex mental activity across the lifespan: development of the lifetime of experiences questionnaire (LEQ). Psychol Med. 2007;37:1015\u201325. https:\/\/doi.org\/10.1017\/S003329170600938X.","journal-title":"Psychol Med"},{"issue":"7S","key":"9330_CR73","doi-asserted-by":"publisher","first-page":"7S_Part_25","DOI":"10.1016\/j.jalz.2018.06.1957","volume":"14","author":"S Roeske","year":"2018","unstructured":"Roeske S, Wolfsgruber S, Kleineidam L, Zulka L, Buerger K, Ewers M, et al. P3\u2010591: a GERMAN version of the lifetime of experiences questionnaire (LEQ) to measure cognitive reserve: validation results from the DELCODE study. Alzheimers Dement. 2018;14:7S_Part_25. https:\/\/doi.org\/10.1016\/j.jalz.2018.06.1957.","journal-title":"Alzheimers Dement"},{"key":"9330_CR74","doi-asserted-by":"publisher","unstructured":"Morris JC, Heyman A, Mohs RC, Hughes JP, Van Belle G, Fillenbaum G, et al. The Consortium to Establish a Registry for Alzheimer\u2019s Disease (CERAD). Part I. Clinical and neuropsychological assesment of Alzheimer\u2019s disease. Neurology. 1989;39:1159\u20131159. https:\/\/doi.org\/10.1212\/WNL.39.9.1159.","DOI":"10.1212\/WNL.39.9.1159"},{"key":"9330_CR75","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1159\/000357774","volume":"4","author":"NS Schmid","year":"2014","unstructured":"Schmid NS, Ehrensperger MM, Berres M, Beck IR, Monsch AU. The extension of the German CERAD neuropsychological assessment battery with tests assessing subcortical, executive and frontal functions improves accuracy in dementia diagnosis. Dement Geriatr Cogn Disord Extra. 2014;4:322\u201334. https:\/\/doi.org\/10.1159\/000357774.","journal-title":"Dement Geriatr Cogn Disord Extra"},{"key":"9330_CR76","unstructured":"Aebi C. Validierung der neuropsychologischen Testbatterie CERAD-NP - Eine Multi-Center Studie. University of Basel; 2002."},{"key":"9330_CR77","volume-title":"Leistungspr\u00fcfsystem f\u00fcr 50\u201390j\u00e4hrige (LPS 50+)","author":"W Sturm","year":"1993","unstructured":"Sturm W, Wilmes K, Horn W. Leistungspr\u00fcfsystem f\u00fcr 50\u201390j\u00e4hrige (LPS 50+). Handanweisung. G\u00f6ttingen: Hogrefe; 1993."},{"key":"9330_CR78","volume-title":"WMS-R: Wechsler Memory Scale\u2013Revised: Manual","author":"D Wechsler","year":"1987","unstructured":"Wechsler D. WMS-R: Wechsler Memory Scale\u2013Revised: Manual. Psychological Corporation; 1987."},{"key":"9330_CR79","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1080\/13854049608406666","volume":"10","author":"D Schretlen","year":"1996","unstructured":"Schretlen D, Bobholz JH, Brandt J. Development and psychometric properties of the brief test of attention. Clin Neuropsychol. 1996;10:80\u20139. https:\/\/doi.org\/10.1080\/13854049608406666.","journal-title":"Clin Neuropsychol"},{"key":"9330_CR80","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1212\/WNL.25.10.907","volume":"25","author":"A Benton","year":"1975","unstructured":"Benton A, Hannay HJ, Varney NR. Visual perception of line direction in patients with unilateral brain disease. Neurology. 1975;25:907\u2013907. https:\/\/doi.org\/10.1212\/WNL.25.10.907.","journal-title":"Neurology"},{"key":"9330_CR81","volume-title":"Contributions to neuropsychological assessment: a clinical manual","author":"AL Benton","year":"1994","unstructured":"Benton AL. Contributions to neuropsychological assessment: a clinical manual. Oxford University Press; 1994."},{"key":"9330_CR82","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1080\/13803390490918273","volume":"27","author":"E Kalbe","year":"2005","unstructured":"Kalbe E, Reinhold N, Brand M, Markowitsch HJ, Kessler J. A new test battery to assess aphasic disturbances and associated cognitive dysfunctions \u2014 German normative data on the Aphasia Check List. J Clin Exp Neuropsychol. 2005;27:779\u201394. https:\/\/doi.org\/10.1080\/13803390490918273.","journal-title":"J Clin Exp Neuropsychol"},{"key":"9330_CR83","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.1007\/s10072-021-05734-w","volume":"43","author":"A Ophey","year":"2022","unstructured":"Ophey A, Krohm F, Kalbe E, Greuel A, Drzezga A, Tittgemeyer M, et al. Neural correlates and predictors of subjective cognitive decline in patients with Parkinson\u2019s disease. Neurol Sci. 2022;43:3153\u201363. https:\/\/doi.org\/10.1007\/s10072-021-05734-w.","journal-title":"Neurol Sci"},{"key":"9330_CR84","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1186\/s13063-024-08265-9","volume":"25","author":"A Ophey","year":"2024","unstructured":"Ophey A, R\u00f6ttgen S, Pauquet J, Wei\u00df K-L, Scharfenberg D, Doppler CEJ, et al. Cognitive training and promoting a healthy lifestyle for individuals with isolated REM sleep behavior disorder: study protocol of the delayed-start randomized controlled trial CogTrAiL-RBD. Trials. 2024;25:428. https:\/\/doi.org\/10.1186\/s13063-024-08265-9.","journal-title":"Trials"},{"key":"9330_CR85","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.22340","volume":"23","author":"CG Goetz","year":"2008","unstructured":"Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez\u2010Martin P, et al. Movement Disorder Society\u2010sponsored revision of the Unified Parkinson\u2019s Disease Rating Scale (MDS\u2010UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008;23:2129\u201370. https:\/\/doi.org\/10.1002\/mds.22340.","journal-title":"Mov Disord"},{"key":"9330_CR86","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/j.1532-5415.1991.tb01616.x","volume":"39","author":"D Podsiadlo","year":"1991","unstructured":"Podsiadlo D, Richardson S. The timed \u201cUp & go\u201d: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991;39:142\u20138. https:\/\/doi.org\/10.1111\/j.1532-5415.1991.tb01616.x.","journal-title":"J Am Geriatr Soc"},{"key":"9330_CR87","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1007\/s10072-018-3564-2","volume":"39","author":"E Zirek","year":"2018","unstructured":"Zirek E, Ersoz Huseyinsinoglu B, Tufekcioglu Z, Bilgic B, Hanagasi H. Which cognitive dual-task walking causes most interference on the Timed Up and Go test in Parkinson\u2019s disease: a controlled study. Neurol Sci. 2018;39:2151\u20137. https:\/\/doi.org\/10.1007\/s10072-018-3564-2.","journal-title":"Neurol Sci"},{"key":"9330_CR88","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S1353-8020(99)00062-0","volume":"6","author":"N Giladi","year":"2000","unstructured":"Giladi N, Shabtai H, Simon ES, Biran S, Tal J, Korczyn AD. Construction of freezing of gait questionnaire for patients with Parkinsonism. Parkinsonism Relat Disord. 2000;6:165\u201370. https:\/\/doi.org\/10.1016\/S1353-8020(99)00062-0.","journal-title":"Parkinsonism Relat Disord"},{"key":"9330_CR89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/982058","volume":"2015","author":"A Vogler","year":"2015","unstructured":"Vogler A, Janssens J, Nyffeler T, Bohlhalter S, Vanbellingen T. German translation and validation of the \u201cFreezing of Gait Questionnaire\u201d in patients with Parkinson\u2019s Disease. Parkinsons Dis. 2015;2015:1\u20135. https:\/\/doi.org\/10.1155\/2015\/982058.","journal-title":"Parkinsons Dis"},{"key":"9330_CR90","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/0895-4356(93)90053-4","volume":"46","author":"RA Washburn","year":"1993","unstructured":"Washburn RA, Smith KW, Jette AM, Janney CA. The physical activity scale for the elderly (PASE): development and evaluation. J Clin Epidemiol. 1993;46:153\u201362. https:\/\/doi.org\/10.1016\/0895-4356(93)90053-4.","journal-title":"J Clin Epidemiol"},{"key":"9330_CR91","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1055\/s-2006-932164","volume":"74","author":"U Lueken","year":"2006","unstructured":"Lueken U, Seidl U, Schwarz M, V\u00f6lker L, Naumann D, Mattes K, et al. Die Apathy Evaluation Scale: Erste Ergebnisse zu den psychometrischen Eigenschaften einer deutschsprachigen \u00dcbersetzung der Skala. Fortschr Neurol Psychiatr. 2006;74:714\u201322. https:\/\/doi.org\/10.1055\/s-2006-932164.","journal-title":"Fortschr Neurol Psychiatr"},{"key":"9330_CR92","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/0165-1781(91)90040-V","volume":"38","author":"RS Marin","year":"1991","unstructured":"Marin RS, Biedrzycki RC, Firinciogullari S. Reliability and validity of the apathy evaluation scale. Psychiatry Res. 1991;38:143\u201362. https:\/\/doi.org\/10.1016\/0165-1781(91)90040-V.","journal-title":"Psychiatry Res"},{"key":"9330_CR93","doi-asserted-by":"publisher","first-page":"274","DOI":"10.13109\/zptm.2006.52.3.274","volume":"52","author":"A Mehnert","year":"2006","unstructured":"Mehnert A, Herschbach P, Berg P, Henrich G, Koch U. Progredienzangst bei Brustkrebspatientinnen - Validierung der Kurzform des Progredienzangstfragebogens PA-F-KF\/ Fear of progression in breast cancer patients \u2013 validation of the short form of the Fear of Progression Questionnaire (FoP-Q-SF). Z Psychosom Med Psychother. 2006;52:274\u201388. https:\/\/doi.org\/10.13109\/zptm.2006.52.3.274.","journal-title":"Z Psychosom Med Psychother"},{"key":"9330_CR94","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1093\/ageing\/afi196","volume":"34","author":"L Yardley","year":"2005","unstructured":"Yardley L, Beyer N, Hauer K, Kempen G, Piot-Ziegler C, Todd C. Development and initial validation of the Falls Efficacy Scale-International (FES-I). Age Ageing. 2005;34:614\u20139. https:\/\/doi.org\/10.1093\/ageing\/afi196.","journal-title":"Age Ageing"},{"key":"9330_CR95","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12955-017-0689-6","volume":"15","author":"SB Jonasson","year":"2017","unstructured":"Jonasson SB, Nilsson MH, Lexell J. Psychometric properties of the original and short versions of the Falls Efficacy Scale-International (FES-I) in people with Parkinson\u2019s disease. Health Qual Life Outcomes. 2017;15:116. https:\/\/doi.org\/10.1186\/s12955-017-0689-6.","journal-title":"Health Qual Life Outcomes"},{"key":"9330_CR96","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1002\/mds.23476","volume":"26","author":"C Trenkwalder","year":"2011","unstructured":"Trenkwalder C, Kohnen R, H\u00f6gl B, Metta V, Sixel\u2010D\u00f6ring F, Frauscher B, et al. Parkinson\u2019s disease sleep scale\u2014validation of the revised version PDSS\u20102. Mov Disord. 2011;26:644\u201352. https:\/\/doi.org\/10.1002\/mds.23476.","journal-title":"Mov Disord"},{"key":"9330_CR97","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1177\/1352458509348519","volume":"15","author":"I Penner","year":"2009","unstructured":"Penner I, Raselli C, St\u00f6cklin M, Opwis K, Kappos L, Calabrese P. The fatigue scale for motor and cognitive functions (FSMC): validation of a new instrument to assess multiple sclerosis-related fatigue. Mult Scler J. 2009;15:1509\u201317. https:\/\/doi.org\/10.1177\/1352458509348519.","journal-title":"Mult Scler J"},{"key":"9330_CR98","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/BF02260863","volume":"4","author":"V Peto","year":"1995","unstructured":"Peto V, Jenkinson C, Fitzpatrick R, Greenhall R. The development and validation of a short measure of functioning and well being for individuals with Parkinson\u2019s disease. Qual Life Res. 1995;4:241\u20138. https:\/\/doi.org\/10.1007\/BF02260863.","journal-title":"Qual Life Res"},{"key":"9330_CR99","doi-asserted-by":"crossref","unstructured":"Berger K, Broil S, Muller T, Ries V. deutschen Version des PDQ-39: Ein krankheitsspezifischer Fragebogen zur Erfassung der Lebensqualit\u00e4t von Parkinson-Patienten. 1999.","DOI":"10.1055\/s-2007-1017628"},{"key":"9330_CR100","doi-asserted-by":"publisher","unstructured":"Jerusalem M, Schwarzer R. SWE - Skala zur Allgemeinen Selbstwirksamkeitserwartung. 2003. https:\/\/doi.org\/10.23668\/PSYCHARCHIVES.4515.","DOI":"10.23668\/PSYCHARCHIVES.4515"},{"issue":"Suppl. 2","key":"9330_CR101","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1159\/000051195","volume":"9","author":"I Hindmarch","year":"1998","unstructured":"Hindmarch I, Lehfeld H, De Jongh P, Erzigkeit H. The Bayer activities of daily living scale (B-ADL). Dement Geriatr Cogn Disord. 1998;9(Suppl. 2):20\u20136. https:\/\/doi.org\/10.1159\/000051195.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"9330_CR102","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1002\/mds.20844","volume":"21","author":"KR Chaudhuri","year":"2006","unstructured":"Chaudhuri KR, Martinez\u2010Martin P, Schapira AHV, Stocchi F, Sethi K, Odin P, et al. International multicenter pilot study of the first comprehensive self\u2010completed nonmotor symptoms questionnaire for Parkinson\u2019s disease: the NMSQuest study. Mov Disord. 2006;21:916\u201323. https:\/\/doi.org\/10.1002\/mds.20844.","journal-title":"Mov Disord"},{"key":"9330_CR103","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/mds.24893","volume":"27","author":"I Litvan","year":"2012","unstructured":"Litvan I, Goldman JG, Tr\u00f6ster AI, Schmand BA, Weintraub D, Petersen RC, et al. Diagnostic criteria for mild cognitive impairment in Parkinson\u2019s disease: Movement disorder society task force guidelines. Mov Disord. 2012;27:349\u201356. https:\/\/doi.org\/10.1002\/mds.24893.","journal-title":"Mov Disord"},{"key":"9330_CR104","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1002\/mds.23362","volume":"25","author":"KL Chou","year":"2010","unstructured":"Chou KL, Amick MM, Brandt J, Camicioli R, Frei K, Gitelman D, et al. A recommended scale for cognitive screening in clinical trials of Parkinson\u2019s disease. Mov Disord. 2010;25:2501\u20137. https:\/\/doi.org\/10.1002\/mds.23362.","journal-title":"Mov Disord"},{"key":"9330_CR105","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1002\/mds.22017","volume":"23","author":"DJ Gill","year":"2008","unstructured":"Gill DJ, Freshman A, Blender JA, Ravina B. The montreal cognitive assessment as a screening tool for cognitive impairment in Parkinson\u2019s disease. Mov Disord. 2008;23:1043\u20136. https:\/\/doi.org\/10.1002\/mds.22017.","journal-title":"Mov Disord"},{"key":"9330_CR106","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1212\/WNL.0b013e3181c34b47","volume":"73","author":"S Hoops","year":"2009","unstructured":"Hoops S, Nazem S, Siderowf AD, Duda JE, Xie SX, Stern MB, et al. Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurology. 2009;73:1738\u201345. https:\/\/doi.org\/10.1212\/WNL.0b013e3181c34b47.","journal-title":"Neurology"},{"key":"9330_CR107","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1136\/jnnp-2016-313838","volume":"87","author":"E Kalbe","year":"2016","unstructured":"Kalbe E, Rehberg SP, Heber I, Kronenbuerger M, Schulz JB, Storch A, et al. Subtypes of mild cognitive impairment in patients with Parkinson\u2019s disease: evidence from the LANDSCAPE study. J Neurol Neurosurg Psychiatry. 2016;87:1099\u2013105. https:\/\/doi.org\/10.1136\/jnnp-2016-313838.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9330_CR108","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1177\/1536867X1601600211","volume":"16","author":"S Cro","year":"2016","unstructured":"Cro S, Morris TP, Kenward MG, Carpenter JR. Reference-based sensitivity analysis via multiple imputation for longitudinal trials with protocol deviation. The Stata Journal: Promoting communications on statistics and Stata. 2016;16:443\u201363. https:\/\/doi.org\/10.1177\/1536867X1601600211.","journal-title":"The Stata Journal: Promoting communications on statistics and Stata"},{"key":"9330_CR109","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3233\/JPD-181473","volume":"8","author":"E Kalbe","year":"2018","unstructured":"Kalbe E, Aarsland D, Folkerts A-K. Cognitive interventions in Parkinson\u2019s disease: where we want to go within 20 years. J Park Dis. 2018;8:107\u201313. https:\/\/doi.org\/10.3233\/JPD-181473.","journal-title":"J Park Dis"},{"key":"9330_CR110","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2023\/9732217","volume":"2023","author":"JS Pigott","year":"2023","unstructured":"Pigott JS, Davies N, Chesterman E, Read J, Nimmons D, Walters K, et al. Delivering optimal care to people with cognitive impairment in Parkinson\u2019s disease: a qualitative study of patient, caregiver, and professional perspectives. Parkinsons Dis. 2023;2023:1\u201316. https:\/\/doi.org\/10.1155\/2023\/9732217.","journal-title":"Parkinsons Dis"},{"key":"9330_CR111","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/J148v21n03_02","volume":"21","author":"KD Lyons","year":"2003","unstructured":"Lyons KD. Self-management of Parkinson\u2019s disease: guidelines for program development and evaluation. Phys Occup Ther Geriatr. 2003;21:17\u201331. https:\/\/doi.org\/10.1080\/J148v21n03_02.","journal-title":"Phys Occup Ther Geriatr"},{"key":"9330_CR112","doi-asserted-by":"publisher","unstructured":"Kulcsarova K, Skorvanek M, Postuma RB, Berg D. Defining Parkinson\u2019s Disease: Past and Future. J Park Dis. 2024:1\u201315. https:\/\/doi.org\/10.3233\/JPD-230411.","DOI":"10.3233\/JPD-230411"},{"key":"9330_CR113","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2024.106065","volume":"123","author":"S Aslam","year":"2024","unstructured":"Aslam S, Manfredsson F, Stokes A, Shill H. Advanced\u201d Parkinson\u2019s disease: a review. Parkinsonism Relat Disord. 2024;123:106065. https:\/\/doi.org\/10.1016\/j.parkreldis.2024.106065.","journal-title":"Parkinsonism Relat Disord"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-025-09330-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-09330-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-09330-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T07:12:57Z","timestamp":1769152377000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13063-025-09330-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,24]]},"references-count":113,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9330"],"URL":"https:\/\/doi.org\/10.1186\/s13063-025-09330-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5446511\/v1","asserted-by":"object"}]},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,24]]},"assertion":[{"value":"13 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures were approved by the Ethics Commission of Cologne University\u2019s Faculty of Medicine, reference number 22-1241_1. Written informed consent to participate is obtained from all participants. Participation is voluntary, and subjects are free to leave the study at any time.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate {24}"}},{"value":"A model consent form will be available upon request from the corresponding author.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication {32}"}},{"value":"P. M. O. reports no competing interests. A. K. F. has received grants from the German Parkinson Society, the German Alzheimer\u2019s Society, the German Parkinson Foundation, STADApharm GmbH, and the General Joint Committee Germany as well as honoraria from Springer Medizin Verlag GmbH, Heidelberg, Germany; Springer-Verlag GmbH, Berlin; ProLog WISSEN GmbH, Cologne, Germany; Seminar- und Fortbildungszentrum Rheine, Germany; LOGOMANIA, Fendt & Sax GbR, Munich, Germany; LOGUAN, Ulm, Germany; dbs e.V., Moers, Germany; STADApharm GmbH, Bad Vilbel, Germany; NEUROPSY, St. Konrad, Austria; Multiple Sclerosis Society Vienna, Vienna, Austria; and Gossweiler Foundation, Bern, Switzerland. A. K. F. is one of the authors of the cognitive intervention series \u201cNEUROvitalis\u201d but receives no corresponding honoraria. E. K. has received grants from the German Ministry of Education and Research, General Joint Committee, Germany, the German Parkinson Society, and STADApharm GmbH, honoraria from AbbVie GmbH Germany and memodio GmbH Germany, and license fees from ProLog GmbH, Germany. E. K. is one of the authors of the cognitive intervention series \u201cNEUROvitalis\u201d but receives no corresponding honoraria. C. v. d. L. was supported by the Cologne Clinician Scientist Program (CCSP), Faculty of Medicine, University of Cologne. M. T. B. received speaker\u2019s honoraria from Medtronic, Boston Scientific, Abbott (formerly St. Jude), FomF, GE Medical, UCB, Bial, Apothekerverband K\u00f6ln e.V., BDN, and Esteve; research funding from the Felgenhauer-Stiftung, Forschungspool Klinische Studien (University of Cologne), Horizon 2020 (Gondola), Medtronic (ODIS, OPEL, BeAble), and Boston Scientific; and advisory honoraria for the IQWiG, Medtronic, Esteve, and AbbVie.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests {28}"}}],"article-number":"76"}}